Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)
Laila Carolina Abu Esba, Majed Al Jeraisy
Abstract
: Efforts of pharmacovigilance in mediating the rare risk of thrombosis associated with COVID-19 vaccine are crucial in providing awareness on the possible risk factors and signs/symptoms that should raise red flags.
Topics & Concepts
MedicinePharmacovigilanceAdverse effectCerebral venous sinus thrombosisThrombosisVaccinationVenous thrombosisPulmonary embolismPediatricsIntensive care medicineEmergency medicineInternal medicineImmunologyHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and ManagementCerebral Venous Sinus Thrombosis